Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients.
Ghandili S, Pfefferle S, Roedl K, Sonnemann P, Karagiannis P, Boenisch O, Kluge S, Schmiedel S, Ittrich H, Rohde H, Lütgehetmann M, Weisel K, Bokemeyer C, Wichmann D, Fiedler W, Jarczak D, Modemann F. Ghandili S, et al. Among authors: karagiannis p. Blood Adv. 2020 Dec 8;4(23):5936-5941. doi: 10.1182/bloodadvances.2020002543. Blood Adv. 2020. PMID: 33275765 Free PMC article.
Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.
Woo MS, Haag F, Nierhaus A, Jarczak D, Roedl K, Mayer C, Brehm TT, van der Meirschen M, Hennigs A, Christopeit M, Fiedler W, Karagiannis P, Burdelski C, Schultze A, Huber S, Addo MM, Schmiedel S, Friese MA, Kluge S, Schulze Zur Wiesch J. Woo MS, et al. Among authors: karagiannis p. iScience. 2021 Jul 23;24(7):102752. doi: 10.1016/j.isci.2021.102752. Epub 2021 Jun 19. iScience. 2021. PMID: 34179733 Free PMC article.
Innate stimulation of B cells ex vivo enhances antibody secretion and identifies tumour-reactive antibodies from cancer patients.
Karagiannis P, Correa I, Chauhan J, Cheung A, Dominguez-Rodriguez D, Terranova-Barberio M, Harris RJ, Crescioli S, Spicer J, Bokemeyer C, Lacy KE, Karagiannis SN. Karagiannis P, et al. Among authors: karagiannis sn. Clin Exp Immunol. 2022 Jan 28;207(1):84-94. doi: 10.1093/cei/uxab005. Clin Exp Immunol. 2022. PMID: 35020866 Free PMC article.
Immunotherapy in Advanced Prostate Cancer-Light at the End of the Tunnel?
von Amsberg G, Alsdorf W, Karagiannis P, Coym A, Kaune M, Werner S, Graefen M, Bokemeyer C, Merkens L, Dyshlovoy SA. von Amsberg G, et al. Among authors: karagiannis p. Int J Mol Sci. 2022 Feb 25;23(5):2569. doi: 10.3390/ijms23052569. Int J Mol Sci. 2022. PMID: 35269712 Free PMC article. Review.
Retrospective analysis of three induction chemotherapy regimens in acute myeloid leukemia including CPX-351, cytarabine/daunorubicin with and without the addition of cladribine.
Klingler F, Alsdorf WH, Ghandili S, Wolschke C, Brauneck F, Bokemeyer C, Fiedler W, Modemann F, Karagiannis P. Klingler F, et al. Among authors: karagiannis p. Leuk Lymphoma. 2022 Nov;63(11):2645-2651. doi: 10.1080/10428194.2022.2092855. Epub 2022 Jul 5. Leuk Lymphoma. 2022. PMID: 35787724
Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells.
Karagiannis P, Singer J, Hunt J, Gan SK, Rudman SM, Mechtcheriakova D, Knittelfelder R, Daniels TR, Hobson PS, Beavil AJ, Spicer J, Nestle FO, Penichet ML, Gould HJ, Jensen-Jarolim E, Karagiannis SN. Karagiannis P, et al. Among authors: karagiannis sn. Cancer Immunol Immunother. 2009 Jun;58(6):915-30. doi: 10.1007/s00262-008-0607-1. Epub 2008 Oct 22. Cancer Immunol Immunother. 2009. PMID: 18941743 Free PMC article.
93 results